Neural Tube Defects (NTDs)

DBCOND0034979Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesNervous System Diseases

Neural Tube Defects (NTDs) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Neural Tube Defects · Neural Tube Defect
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0014686SNOMED CT253098009MedDRA10052046UMLSC0027794

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Neural Tube Defects (NTDs) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In